DS06652923
DS06652923 is an orally active EGFR triple mutation inhibitor. DS06652923 has a growth inhibition effect on Ba/F3 EGFR del19/T90M/C797S cells, with a GI50 value of 9.4 nM. DS06652923 can lead to tumor regression in Ba/F3 xenograft models[1].
Product Specifications
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ds06652923.html
Smiles
CC(C)OC1=CC(NC2=CC=NC(C3=CN(S(=O)(C4CC4)=O)N=C3)=N2)=NC=C1C5=CN(C6CCN(C)CC6)N=C5OC(F)F
Molecular Formula
C28H33F2N9O4S
Molecular Weight
629.68
References & Citations
[1]Kageji H, et al. Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity. Bioorg Med Chem. 2024 Sep 1;111:117862.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6471735-01 0.2 mL
CYP4F12, CT (Cytochrome P450 4F12, CYPIVF12, UNQ568/PRO1129) (APC)
Ask
View Details MBS6471735-02 5x 0.2 mL
CYP4F12, CT (Cytochrome P450 4F12, CYPIVF12, UNQ568/PRO1129) (APC)
Ask
View Details W3036-ML750 100 µL
Wnt6 (Wingless-type MMTV (Mouse Mammary Tumor Virus) Integration Site Family, Member 6 (Wnt6) (MaxLight 750) discontinued
Ask
View Details 